AzTrials
AzTrials

SepsisNeoCALMNCT06811428

Neonatal Comfort Seat Allowing Safe Lumbar Puncture and Minimizing Failure: a Randomized Controlled Trial

A study testing A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS) in people with Sepsis and Meningitis, run by Joel Cox.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS). Read more about this study

Who is it for?
Ages 0 to 28 days
Conditions the study is for
Sepsis, Meningitis
What is being tested?
A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
No sites listed yet
Study dates
1 Mar 2025to 1 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Late preterm (34 + weeks) Gestational Age to Term (42+ weeks GA)
  • Weight of 2.5 - 5 kg

Who cannot join

  • Any contraindication to having a lumbar punture procedure

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine contact

+19029664400

Joel.Cox@gatewaypaeds.ca

Amanda Latham, N/A contact

+19029664400

admin@gatewaypaeds.ca

About this study

A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS).

The research question is:

Read more

P: In late-preterm to term babies who are 0-28 days and undergoing LP for R/O Sepsis I: Is the LPCS more effective C: Than human/RN assisted upright positioning O: In generating a higher rate of first attempt LP success

Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)

Secondary outcome measures could include

  1. A qualitatively unadulterated tap (no blood) although as you know this is hard to control even with perfect positioning and technique and single pass
  2. A difference in FLACC score as measure of overall pain/comfort between test and control
Read the detailed description

Lay Description: Newborn babies who are unwell sometimes need to undergo a medical procedure known as a 'lumbar puncture' (also called 'spinal tap'). During this procedure, a needle is inserted at the base of the spine to extract fluid from the spinal column. This is most often done to determine if the baby has meningitis. The medical device presented here places the child's comfort and safety at the center of the spinal tap/ lumbar puncture experience and in doing increases the success of this otherwise stressful and technically challenging procedure. This is achieved by placing the child in a stable, firm, but comfortable position nearly eliminating patient motion which otherwise interferes with procedure success, and reduces the variability associated with a human assistant/holder

In the course of routine medical care of infants and young children, it may be necessary to conduct a procedure known as a 'lumbar puncture' or 'spinal tap' which involves insertion of a needle into the base of the spinal column in order to extract fluid for diagnostic purposes. The goal is to obtain a fluid sample with minimal trauma on the first attempt. The target space into which the operator is aiming to access this fluid is approx. 3 mm in diameter. First attempt failure rates range from 30-50%. A second try immediately following a first try, even if successful, leads to more trauma to the patient and often a sub-optimal sample (the "bloody tap") due to surrounding tissue/vascular disruption.

Many factors may contribute to first attempt success in this procedure:

  1. The clinical condition of the baby including hydration
  2. How well pain is controlled (assisting in the reduction of movement)
  3. The experience and confidence of the operator conducting the procedure and technique
  4. The experience of the assistant positioning the baby. This factor is generally accepted among clinicians as the most important factor contributing to procedure outcome and yet it is highly variable.

The lumbar puncture procedure may be conducted with the baby placed in a side-lying position. The side-lying position is most common, historically, as the patient seems to be more stable. However the alignment of the spine is often disrupted.

The upright sitting position may also be used. There is recent compelling evidence that this position is superior to the side lying position (NeoCLEAR Study 2023)

The sitting position is associated with better outcomes but is often avoided as the holding technique is more complex

The problem which the current innovation seeks to resolve is the high degree of variability in quality, consistency, and reproducibility of a positioning/immobilization of the neonatal patient during the lumbar puncture procedure.

Conditions
Sepsis, Meningitis
Being tested
A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS), Standard of Care (SOC)
Keywords
Lumbar puncture, Seating device, Positioning device, Newborn, Neonatal, Meningitis, Sepsis
Medical subject headings
Sepsis, Meningitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)Device

    The participant will be placed in the LPCS for their lumbar puncture procedure

  • Standard of Care (SOC)Other

    The patient will be held in the upright position by a human assistant

Study groups in NCT06811428
Study groupRoleWhat they receive
Lumbar Puncture Comfort Seat ArmExperimentalThis is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the medical device
Receives: Device: A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)
Standard of Care ArmActive comparatorThis is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the human assistant which is present standard of care
Receives: Other: Standard of Care (SOC)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First attempt LP success

    Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)

    Measured: Assessed at each procedure

Secondary outcomes (2)
  1. Clear tap

    A qualitatively unadulterated tap (no blood)

    Measured: Assessed at each procedure

  2. FLACC Score

    A difference in FLACC score as measure of overall pain/comfort between test and control

    Measured: Assessed at each procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2025
  2. Study start1 Mar 2025 (estimated)
  3. Primary completion1 Mar 2026 (estimated)
  4. Study completion1 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
68 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06811428
Sponsor's protocol ID
LPCSRCT2025
Acronym
NeoCALM
Status last verified
Jan 2025
First submitted
31 Jan 2025
Last updated
6 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Marshall ASJ, Sadarangani M, Scrivens A, Williams R, Yong J, Bowler U, Linsell L, Chiocchia V, Bell JL, Stokes C, Santhanadass P, Adams E, Juszczak E, Roehr CC; 'The NeoCLEAR Collaborative Group'. Study protocol: NeoCLEAR: Neonatal Champagne Lumbar punctures Every time - An RCT: a multicentre, randomised controlled 2 x 2 factorial trial to investigate techniques to increase lumbar puncture success. BMC Pediatr. 2020 Apr 15;20(1):165. doi: 10.1186/s12887-020-02050-8.

    PubMed 32295554

Questions about this trial

What is this clinical trial studying?

A study testing A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS) in people with Sepsis and Meningitis, run by Joel Cox.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine (+19029664400, Joel.Cox@gatewaypaeds.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First attempt LP success (time frame: Assessed at each procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06811428, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in